Why Didn't Pfizer and BioNTech Stocks Soar After Their COVID Vaccine Achieved 100% Efficacy in Kids?

Credit: Motley Fool- Published 1 week ago
There are several potential reasons why investors didn't cheer the companies' great news more loudly.

You are here


Related videos from verified sources

Teen describes experience on Pfizer vaccine trial, 13-year-old participant says she had sore arm and fever 01:05
Credit: 23ABC News | Bakersfield - Published 2 weeks ago 


Study shows Pfizer vaccine effective for kids 12 to 15 00:14
Credit: KDVR - Published 2 weeks ago 


Pfizer says its COVID-19 vaccine protects kids as young as 12, shots could start by next school year 00:30
Credit: FOX 4 Now Florida - Published 2 weeks ago 


You might like